Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01178008
Other study ID # Acup-003
Secondary ID
Status Completed
Phase N/A
First received August 1, 2010
Last updated January 14, 2013
Start date May 2010
Est. completion date June 2012

Study information

Verified date January 2013
Source The University of Hong Kong
Contact n/a
Is FDA regulated No
Health authority Hong Kong: Department of Health
Study type Interventional

Clinical Trial Summary

The proposed study is a randomized controlled trial to examine the efficacy and safety of active acupuncture versus placebo acupuncture for the treatment of postpartum depression. The investigators hypothesis is that active acupuncture would be superior to placebo acupuncture in the short-term treatment of postpartum depression.


Description:

This study will be a randomized, controlled, subject- and assessor-blind trial in patients with postpartum depression. Eligible subjects will be randomly assigned to active acupuncture or placebo acupuncture. The subjects will receive acupuncture treatment twice per week for 4 consecutive weeks. The acupuncturist of this trial will not participate in data collection and data entry. The trial assessor will be blind to the subjects' treatment allocation.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date June 2012
Est. primary completion date December 2011
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Ethnic Hong Kong Chinese aged 18 years or above;

- Within 6 months of giving birth;

- Edinburgh Postnatal Depression Scale (EPDS) (Cox et al., 1987) score higher than or equal to 12 or being diagnosed as depressed by their obstetrician;

- Meeting the Diagnostic and Statistical Manual of Mental Disorders-IV diagnosis criteria for major depressive disorder;

- 17-item Hamilton Depression Rating Scale (HDRS17) (Hamilton, 1960) score of between 12 and 19 at screening and baseline assessment;

- Willingness to give informed consent and comply with trial protocol.

Exclusion Criteria:

- Suffering from other psychiatric disorders such as schizophrenia, other psychotic disorders, bipolar disorder or substance use disorder;

- Serious physical illnesses or mental disorders due to a general medical condition which are judged by the investigator to render unsafe;

- A significant risk of suicide according to the rating of HDRS17 item 3 (score higher than 2), i.e., presence of ideas or gesture of suicide;

- A presence of idea of self-harming according to the rating of EPDS item 10 (score higher than 0);

- A significant risk of infanticide according to the investigator assessment;

- Any acupuncture treatment during the previous 12 months prior to baseline;

- Valvular heart defects, bleeding disorders or taking anticoagulant drugs;

- Infection or abscess close to the site of selected acupoints;

- Herbal remedies or psychotropic drugs that are intended for depression are taken within the last 2 weeks prior to baseline or during the study.

- Receiving counseling or psychological therapies at baseline or during the study;

- Participation in any clinical trial within the previous 3 months prior to baseline;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Intervention

Procedure:
Active acupuncture
Active acupuncture regimen consists of electroacupuncture stimulation on cranial and body acupoints which are empirical for treating depression in term of traditional Chinese medicine theory. It is done by a registered Chinese medicine practitioner with at least 3 years experience of providing acupuncture treatment. An electric-stimulator is connected to these needles to give an electric-stimulation in a continuous wave The needles will be left for 30 min and then removed. Acupuncture treatment will consist of two sessions per week for 4 consecutive weeks.
Placebo acupuncture
Streitberger's non-invasive acupuncture needles will be applied to serve as placebo control at the same acupoints and the same stimulation modality, except that the needles only affixed on the skin with adhesive tapes instead of insertion. Since all the points used are beyond patients' vision as they lay on bed, they could not visualize the acupuncture procedure. The acupuncturist, setting, treatment frequency, and duration of the treatment course are the same as the active acupuncture group.

Locations

Country Name City State
Hong Kong Kwong Wah Hospital Hong Kong
Hong Kong Queen Mary Hospital Hong Kong
Hong Kong Tsan Yuk Hospital Hong Kong

Sponsors (3)

Lead Sponsor Collaborator
The University of Hong Kong Hospital Authority, Hong Kong, Kwong Wah Hospital

Country where clinical trial is conducted

Hong Kong, 

References & Publications (2)

Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987 Jun;150:782-6. — View Citation

HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary 17-item Hamilton Depression Rating Scale To assess Depressive symptoms 8 weeks Yes
Secondary Hospital Anxiety and Depression Scale (HADS) To assess depression and anxiety 8 weeks No
Secondary Sheehan Disability Scale To assess subjects' functioning in work/study, social life and family 8 weeks No
Secondary Clinical Global Impression Scale To assess severity of illness and improvement due to treatment 8 weeks No
Secondary Edinburgh Postnatal Depression Scale To assess subjective Depressive symptoms 8 weeks Yes
See also
  Status Clinical Trial Phase
Recruiting NCT05077644 - Mobile Application in the Management of Mild to Moderate Postpartum Depression (PPD) N/A
Active, not recruiting NCT03416010 - Healthy Lifestyle Intervention for High-Risk Minority Pregnant Women N/A
Withdrawn NCT02738021 - Managing PPD at Gouverneur N/A
Recruiting NCT06208852 - Virtual Patient Navigation During a Pandemic N/A
Withdrawn NCT02741206 - Preventing Postpartum Depression in Prenatal Care N/A
Completed NCT00373750 - Cradling Our Future Through Family Strengthening Study N/A
Recruiting NCT05518162 - Treatment of Post-partum Depression Using an Behavioral Intervention Called ROSE (Reach Out, Stay Strong, Essentials for Mothers of Newborns) Delivered Using an Electronic App N/A
Not yet recruiting NCT06131255 - DRACULA1 Partum Depression: an Integrated Molecular-pharmaco-imaging Study")
Not yet recruiting NCT06285916 - A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression Phase 2
Completed NCT01407783 - Systems of Care for New Moms: Integrating Depression Treatment N/A